EFNB2 and cancer: The EPHB4 and ephrin-B2 overexpression shape, in conjunction with several other genes, a more malignant clinical phenotype [61], which is partially parallel to the fact that ephrin-B2′s expression correlates with the TNM Classification of Malignant Tumors (TNM) staging [57].